Ayman Soubani

Dr. Ayman Soubani

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2011 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
MKM. Kousha
M. Kousha
RTR. Tadi
R. Tadi
Ayman SoubaniAyman Soubani
Ayman Soubani
Aspergillusis a mould which may lead to a variety of infectious, allergic diseases depending on the host's immune status or pulmonary structure. Invasive pulmonary aspergillosis occurs primarily in patients with severe immunodeficiency. The significance of this infection has dramatically increased with growing numbers of patients with impaired immune state associated with the management of malignancy, organ transplantation, autoimmune and inflammatory conditions; critically ill patients and those with chronic obstructive pulmonary disease appear to be at an increased risk. The introduction of new noninvasive tests, combined with more effective and better-tolerated antifungal agents, has resulted in lower mortality rates associated with this infection. Chronic necrotising aspergillosis is a locally invasive disease described in patients with chronic lung disease or mild immunodeficiency. Aspergilloma is usually found in patients with previously formed cavities in the lung, whereas allergic bronchopulmonary aspergillosis, a hypersensitivity reaction toAspergillusantigens, is generally seen in patients with atopy, asthma or cystic fibrosis. This review provides an update on the evolving epidemiology and risk factors of the major manifestations ofAspergilluslung disease and the clinical manifestations that should prompt the clinician to consider these conditions. Current approaches for the diagnosis and management of these syndromes are discussed.

1 August 2018 in Respiratory Medicine
Verified
Journal Article
Closed access
AKAmjad Kanj
Amjad Kanj
NANadine Abdallah
Nadine Abdallah
Ayman SoubaniAyman Soubani
Ayman Soubani

1 July 2021 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
HBHarsha Banavasi
Harsha Banavasi
PNPaul Nguyen
Paul Nguyen
HOHeba Osman
Heba Osman
Ayman SoubaniAyman Soubani
Ayman Soubani

1 November 2004 in Chest
Verified
Journal Article
Closed access
PDF file
Ayman SoubaniAyman Soubani
Ayman Soubani
EKEiad Kseibi
Eiad Kseibi
JBJoseph J. Bander
Joseph J. Bander
JKJared L. Klein
Jared L. Klein
GKGeeta Khanchandani
Geeta Khanchandani
JGJorge A. Guzman
Jorge A. Guzman

30 April 2007 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
Ayman SoubaniAyman Soubani
Ayman Soubani
JUJ. P. Uberti
J. P. Uberti
The aim of the present article is to review the available clinical data on bronchiolitis obliterans following haematopoietic stem cell transplantation (HSCT).The data sources used were the Medline database and references from the identified articles related to bronchiolitis obliterans, noninfectious pulmonary complications and HSCT.HSCT is an important treatment for a variety of malignant and nonmalignant conditions. However, the procedure is limited by significant complications that may involve every organ of the body. Pulmonary complications are seen in 40–60% of HSCT recipients. The recent advances in prophylaxis and treatment of infectious complications have increased the significance of late noninfectious pulmonary conditions.Currently, bronchiolitis obliterans is one of the most challenging pulmonary complications facing clinicians who are taking care of haematopoietic stem cell transplantation recipients. This article reviews the clinical and pathological features of this condition, sheds some light on potential mechanisms of pathogenesis, and discusses the available management options.

1 June 2020 in The American Journal of Medicine
Verified
Journal Article
Closed access
FEFiras El-Baba
Firas El-Baba
YGYuqing Gao
Yuqing Gao
Ayman SoubaniAyman Soubani
Ayman Soubani